Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Real-time process/quality control for HPC processing.

M Arpagaus1, E Oppliger Leibundgut, K Zbären

  • 1Hematology Department, University Hospital Inselspital, Berne, Switzerland.

Cytotherapy
|October 30, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Estimating the uptake of traffic-derived NO<sub>2</sub> from <sup>15</sup>N abundance in Norway spruce needles.

Oecologia·2017
Same author

Incorporation of atmospheric <sup>15</sup>NO<sub>2</sub>-nitrogen into free amino acids by Norway spruce Picea abies (L.) Karst.

Oecologia·2017
Same author

Laboratory recommendations for scoring deep molecular responses following treatment for chronic myeloid leukemia.

Leukemia·2015
Same author

Regulation of adenosine-5'-phosphosulfate sulfotransferase activity by H2S in Lemna minor L.

Planta·2014
Same author

Localization of adenosine 5'-phosphosulfate sulfotransferase in spinach leaves.

Planta·2014
Same author

Regulation of adenosine 5'-phosphosulfate sulfotransferase activity by H2S and cyst(e)ine in primary leaves of Phaseolus vulgaris L.

Planta·2013
Same journal

CAR T cells: The next frontier.

Cytotherapy·2026
Same journal

Dialysis bioreactor enables high-density, serum-free expansion of dental pulp-derived mesenchymal stromal cells with enhanced secretome.

Cytotherapy·2026
Same journal

Beyond the synapses: should we anticipate neurotransmitter signaling when manufacturing CAR-T cells for brain tumors?

Cytotherapy·2026
Same journal

Curative treatment for severe sickle cell disease: allogeneic hematopoietic cell transplant or gene therapy.

Cytotherapy·2026
Same journal

Manufacturing strategies for prolonged CAR-T cell persistence.

Cytotherapy·2026
Same journal

Overcoming five main challenges to targeting hematologic malignancies.

Cytotherapy·2026
See all related articles

A new real-time quality control system was developed for hematopoietic progenitor cell (HPC) processing to meet JACIE Standards. This system ensures consistent cell quality and aids in process validation for improved transplantation outcomes.

Area of Science:

  • Hematology
  • Cell Processing
  • Quality Control

Background:

  • JACIE Standards have been implemented in Europe since 1999.
  • An on-site accreditation inspection occurred in January 2004.
  • The need for a real-time process/quality control system for HPC release was identified.

Purpose of the Study:

  • To develop a real-time process and quality control system for hematopoietic progenitor cell (HPC) release.
  • To ensure compliance with JACIE Standards for HPC processing.
  • To establish a robust system for quality assurance in cell therapy.

Main Methods:

  • Analysis of 194 HPC processing procedures for autologous transplantation over 5 years.
  • Comparison of four processing methods: cryopreservation without washing, washing cells, cell-density separation, and positive CD34 selection.

Related Experiment Videos

  • Identification and validation of four critical control points for HPC processing.

    • Main Results:

    • Defined acceptable value ranges for critical control points based on statistical analysis.
    • Implemented real-time quality control using defined acceptable values for cell release.
    • Demonstrated the ability to validate HPC processing and ensure product quality.

    Conclusions:

    • A model for validating HPC processing and a real-time quality control system for HPC release have been developed.
    • Standardization of methods and inter-facility comparisons are crucial for external quality control.
    • This system facilitates quality improvement in hematopoietic progenitor cell processing.